Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Payables (2019 - 2025)

IM Cannabis has reported Payables over the past 7 years, most recently at $18.9 million for Q4 2025.

  • Quarterly results put Payables at $18.9 million for Q4 2025, changed 0.49% from a year ago — trailing twelve months through Dec 2025 was $18.9 million (changed 0.49% YoY), and the annual figure for FY2025 was $18.9 million, down 1.7%.
  • Payables for Q4 2025 was $18.9 million at IM Cannabis, roughly flat from $18.8 million in the prior quarter.
  • Over the last five years, Payables for IMCC hit a ceiling of $18.9 million in Q4 2025 and a floor of $1.2 million in Q2 2024.
  • Median Payables over the past 5 years was $16.9 million (2022), compared with a mean of $13.9 million.
  • Biggest five-year swings in Payables: soared 430.07% in 2021 and later fell 13.35% in 2023.
  • IM Cannabis' Payables stood at $10.6 million in 2021, then skyrocketed by 70.81% to $18.1 million in 2022, then fell by 13.35% to $15.7 million in 2023, then rose by 20.11% to $18.8 million in 2024, then increased by 0.49% to $18.9 million in 2025.
  • The last three reported values for Payables were $18.9 million (Q4 2025), $18.8 million (Q4 2024), and $1.2 million (Q2 2024) per Business Quant data.